Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan P Bennett

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Antiviral Research|September 30, 2023
Corrigendum to "Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase" [Antivir. Res. 218 (2023) 105716-105728, doi: 10.1016/j.antiviral.2023.105716]Ryan P Bennett, Yasemin Yoluç, Jason D Salter, et al.
Antiviral Research|September 10, 2023
Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymeraseRyan P Bennett, Yasemin Yoluç, Jason D Salter, et al.
The Journal of Biological Chemistry|November 3, 2006
Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunitsJoseph E Wedekind, Richard Gillilan, Alena Janda, et al.
The Journal of Biological Chemistry|April 7, 2017
DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315Bogdan Polevoda, Rebecca Joseph, Alan E Friedman, et al.
The Journal of Biological Chemistry|November 12, 2021
Cyclic peptides with a distinct arginine-fork motif recognize the HIV trans-activation response RNA in vitro and in cellsSai Shashank Chavali, Sachitanand M Mali, Rachel Bonn, et al.
Viruses|January 5, 2021
A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical CountermeasuresRyan P Bennett, Courtney L Finch, Elena N Postnikova, et al.
ACS Chemical Biology|October 27, 2015
N-Methylation as a Strategy for Enhancing the Affinity and Selectivity of RNA-binding Peptides: Application to the HIV-1 Frameshift-Stimulating RNAThomas A Hilimire, Ryan P Bennett, Ryan A Stewart, et al.
JCI Insight|November 22, 2021
Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug propertiesRyan P Bennett, Elena N Postnikova, Brett P Eaton, et al.
Antiviral Research|November 10, 2016
An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradationRyan P Bennett, Ryan A Stewart, Priscilla A Hogan, et al.
ACS Chemical Biology|April 28, 2017
HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human CellsThomas A Hilimire, Jeffrey M Chamberlain, Viktoriya Anokhina, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Antiviral Research|September 30, 2023
Corrigendum to "Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase" [Antivir. Res. 218 (2023) 105716-105728, doi: 10.1016/j.antiviral.2023.105716]Ryan P Bennett, Yasemin Yoluç, Jason D Salter, et al.
Antiviral Research|September 10, 2023
Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymeraseRyan P Bennett, Yasemin Yoluç, Jason D Salter, et al.
The Journal of Biological Chemistry|November 3, 2006
Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunitsJoseph E Wedekind, Richard Gillilan, Alena Janda, et al.
The Journal of Biological Chemistry|April 7, 2017
DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315Bogdan Polevoda, Rebecca Joseph, Alan E Friedman, et al.
The Journal of Biological Chemistry|November 12, 2021
Cyclic peptides with a distinct arginine-fork motif recognize the HIV trans-activation response RNA in vitro and in cellsSai Shashank Chavali, Sachitanand M Mali, Rachel Bonn, et al.
Viruses|January 5, 2021
A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical CountermeasuresRyan P Bennett, Courtney L Finch, Elena N Postnikova, et al.
ACS Chemical Biology|October 27, 2015
N-Methylation as a Strategy for Enhancing the Affinity and Selectivity of RNA-binding Peptides: Application to the HIV-1 Frameshift-Stimulating RNAThomas A Hilimire, Ryan P Bennett, Ryan A Stewart, et al.
JCI Insight|November 22, 2021
Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug propertiesRyan P Bennett, Elena N Postnikova, Brett P Eaton, et al.
Antiviral Research|November 10, 2016
An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradationRyan P Bennett, Ryan A Stewart, Priscilla A Hogan, et al.
ACS Chemical Biology|April 28, 2017
HIV-1 Frameshift RNA-Targeted Triazoles Inhibit Propagation of Replication-Competent and Multi-Drug-Resistant HIV in Human CellsThomas A Hilimire, Jeffrey M Chamberlain, Viktoriya Anokhina, et al.
Pageof 2